Evidence map›Paper›PMID 28824631›Full record

ArticleFrontiers in immunology2017

The Extracts of

Jian Liang, Jiwang Liang, Hairong Hao, Huan Lin, Peng Wang, Yanfang Wu, Xiaoli Jiang, Chaodi Fu, Qian Li, Ping Ding and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Anti-inflammatory activity of Chlorella polysaccharide AHP.Molecular and cellular biochemistry · 2026
    Article
  2. Review
  3. [Therapeutic effects of inulin-type oligosaccharides ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Heliyon · 2022
    Article
  11. Article
  12. Alkaloids fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Jian LiangGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jiwang LiangShenzhen Fan Mao Pharmaceutical Co., Limited, Shenzhen, China.
Hairong HaoAffiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, China.
Huan LinGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Peng WangShenzhen Fan Mao Pharmaceutical Co., Limited, Shenzhen, China.
Yanfang WuGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaoli JiangShenzhen Fan Mao Pharmaceutical Co., Limited, Shenzhen, China.
Chaodi FuShenzhen Fan Mao Pharmaceutical Co., Limited, Shenzhen, China.
Qian LiGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Ping DingGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Huazhen LiuSection of Immunology, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
Qingping XiongGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xiaoping LaiGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Lian ZhouGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Shamyuen ChanShenzhen Fan Mao Pharmaceutical Co., Limited, Shenzhen, China.
Shaozhen HouGuangdong Provincial Key Laboratory of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CNGuangdong Academy of Medical Sciences · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-inflammatoryapoptosishairy roots cultureimmunoregulatoryMorinda officinalisulcerative colitis

Identifiers

PMID28824631
PMCPMC5539173
OpenAlexW2740118715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.